Cargando…

Telomere-related Markers for Cancer

Telomeres are structurally nucleoprotein complexes at termini of linear chromosomes and essential to chromosome stability/integrity. In normal human cells, telomere length erodes progressively with each round of cell divisions, which serves as an important barrier to uncontrolled proliferation and m...

Descripción completa

Detalles Bibliográficos
Autores principales: Yuan, Xiaotian, Dai, Mingkai, Xu, Dawei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bentham Science Publishers 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7475940/
https://www.ncbi.nlm.nih.gov/pubmed/31903880
http://dx.doi.org/10.2174/1568026620666200106145340
_version_ 1783579619992010752
author Yuan, Xiaotian
Dai, Mingkai
Xu, Dawei
author_facet Yuan, Xiaotian
Dai, Mingkai
Xu, Dawei
author_sort Yuan, Xiaotian
collection PubMed
description Telomeres are structurally nucleoprotein complexes at termini of linear chromosomes and essential to chromosome stability/integrity. In normal human cells, telomere length erodes progressively with each round of cell divisions, which serves as an important barrier to uncontrolled proliferation and malignant transformation. In sharp contrast, telomere maintenance is a key feature of human malignant cells and required for their infinite proliferation and maintenance of other cancer hallmarks as well. Thus, a telomere-based anti-cancer strategy has long been suggested. However, clinically efficient and specific drugs targeting cancer telomere-maintenance have still been in their infancy thus far. To achieve this goal, it is highly necessary to elucidate how exactly cancer cells maintain functional telomeres. In the last two decades, numerous studies have provided profound mechanistic insights, and the identified mechanisms include the aberrant activation of telomerase or the alternative lengthening of telomere pathway responsible for telomere elongation, dysregulation and mutation of telomere-associated factors, and other telomere homeostasis-related signaling nodes. In the present review, these various strategies employed by malignant cells to regulate their telomere length, structure and function have been summarized, and potential implications of these findings in the rational development of telomere-based cancer therapy and other clinical applications for precision oncology have been discussed.
format Online
Article
Text
id pubmed-7475940
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Bentham Science Publishers
record_format MEDLINE/PubMed
spelling pubmed-74759402020-09-16 Telomere-related Markers for Cancer Yuan, Xiaotian Dai, Mingkai Xu, Dawei Curr Top Med Chem Chemistry Telomeres are structurally nucleoprotein complexes at termini of linear chromosomes and essential to chromosome stability/integrity. In normal human cells, telomere length erodes progressively with each round of cell divisions, which serves as an important barrier to uncontrolled proliferation and malignant transformation. In sharp contrast, telomere maintenance is a key feature of human malignant cells and required for their infinite proliferation and maintenance of other cancer hallmarks as well. Thus, a telomere-based anti-cancer strategy has long been suggested. However, clinically efficient and specific drugs targeting cancer telomere-maintenance have still been in their infancy thus far. To achieve this goal, it is highly necessary to elucidate how exactly cancer cells maintain functional telomeres. In the last two decades, numerous studies have provided profound mechanistic insights, and the identified mechanisms include the aberrant activation of telomerase or the alternative lengthening of telomere pathway responsible for telomere elongation, dysregulation and mutation of telomere-associated factors, and other telomere homeostasis-related signaling nodes. In the present review, these various strategies employed by malignant cells to regulate their telomere length, structure and function have been summarized, and potential implications of these findings in the rational development of telomere-based cancer therapy and other clinical applications for precision oncology have been discussed. Bentham Science Publishers 2020-03 2020-03 /pmc/articles/PMC7475940/ /pubmed/31903880 http://dx.doi.org/10.2174/1568026620666200106145340 Text en © 2020 Bentham Science Publishers https://creativecommons.org/licenses/by-nc/4.0/legalcode This is an open access article licensed under the terms of the Creative Commons Attribution-Non-Commercial 4.0 International Public License (CC BY-NC 4.0) (https://creativecommons.org/licenses/by-nc/4.0/legalcode), which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.
spellingShingle Chemistry
Yuan, Xiaotian
Dai, Mingkai
Xu, Dawei
Telomere-related Markers for Cancer
title Telomere-related Markers for Cancer
title_full Telomere-related Markers for Cancer
title_fullStr Telomere-related Markers for Cancer
title_full_unstemmed Telomere-related Markers for Cancer
title_short Telomere-related Markers for Cancer
title_sort telomere-related markers for cancer
topic Chemistry
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7475940/
https://www.ncbi.nlm.nih.gov/pubmed/31903880
http://dx.doi.org/10.2174/1568026620666200106145340
work_keys_str_mv AT yuanxiaotian telomererelatedmarkersforcancer
AT daimingkai telomererelatedmarkersforcancer
AT xudawei telomererelatedmarkersforcancer